Goldman Sachs is updating its Illumina Inc. ILMN estimates to reflect “our latest sequencing system placement assumptions for both HiSeq and MiSeq for 2011-2014.”
“We now believe the mix will shift more towards MiSeq than HiSeq and as a result our 2011-2013 EPS estimates go to $1.55, $2.04, $2.64 from $1.55, $2.08, $2.70, respectively,” Goldman Sachs writes.
Illumina closed Thursday at $74.13.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in